Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Attend a group training Schedule a 1-on-1 guided demo Watch a demo video
1726121530-2ff8c6826d51d076
Name
Christina Coughlin
Title
CEO
Bio
Dr. Coughlin, M.D., Ph.D. was previously the Chief Executive Officer of Cytolmmune Therapeutics LLC, a clinical-stage biotechnology company, focused on the development and commercialisation of novel cancer immunotherapy products designed to use the patient’s own immune system to eliminate cancer cells. She also served as Chief Medical Officer to Rubius Therapeutics. Inc, where she led the clinical development, translational medicine and regulatory efforts in the allogeneic red cell therapy platform. Prior to Rubius, Dr. Coughlin was with Tmunity Therapeutics, Inc., where she served as Chief Medical Officer and was responsible for the development of autologous CAR-T and TCR-T cellular therapies.